Dawn R. Cochrane

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

Dawn R. Cochrane, Sebastián Bernales, Britta M. Jacobsen et al. · Breast Cancer Research · 2014 · 391 citations · Full text

Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer

Allen W. Zhang, Andrew McPherson, Katy Milne et al. · Cell · 2018 · 373 citations

Malignant Disease, Tumor Heterogeneity, Medicine +9

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

Dawn R. Cochrane, Nicole S. Spoelstra, Erin N. Howe et al. · Molecular Cancer Therapeutics · 2009 · 312 citations · Full text

A TDO2-AhR Signaling Axis Facilitates Anoikis Resistance and Metastasis in Triple-Negative Breast Cancer

Nicholas C. D’Amato, Thomas J. Rogers, Melita A. Gordon et al. · Cancer Research · 2015 · 293 citations

Breast Oncology, Cell Death, Cancer Biology +19

Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes

Yi Kan Wang, Ali Bashashati, Michael S. Anglesio et al. · Nature Genetics · 2017 · 284 citations

Genome Instability, Genomic Consequences, Somatic Variant +8